Immunobiotics Stock Price, News & Analysis
Company Description
Immunobiotics (NASDAQ: IMBI) is a publicly traded all other miscellaneous store retailers (except tobacco stores) company in the Retail Trade sector. The company has a market capitalization of $3.2M.
IMBI stock has declined 100.0% over the past year.
This page provides a comprehensive overview of IMBI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Immunobiotics (IMBI) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $3.2M, IMBI is classified as a micro-cap stock.
Latest News
Immunobiotics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings. View all IMBI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
IMBI Company Profile & Sector Positioning
Immunobiotics (IMBI) operates in the All Other Miscellaneous Store Retailers (except Tobacco Stores) industry within the broader Retail Trade sector and is listed on the NASDAQ.